Rose O'Reilly

Rose O'Reilly has a diverse work experience in the field of bioscience. Rose is currently employed at bit.bio as a Senior Scientist (Group Leader) in Drug Product Process Development since April 2022. Prior to this, they worked as a Scientist - Manufacturing Development at the same company from December 2020 to April 2022. Rose also served as a Research Assistant at bit.bio from July 2020 to December 2020.

Before joining bit.bio, Rose worked at Axol Bioscience Ltd. as a Research Assistant from June 2019 to July 2020. In this role, they led high-value service projects involving the generation of iPS cells from diseased donor PBMC and fibroblasts. Rose was responsible for culturing fibroblasts, PBMCs, iPSCs, and neural cell types, as well as differentiating iPSCs into neural stem cells.

From January 2019 to June 2019, Rose worked at Tetrad Discovery Ltd. as a Senior Associate Scientist. Rose'sresponsibilities included working on studies involving biomarkers of pain and osteoarthritis, as well as cytotoxicity and pharmacology studies using cell and plate-based assays. Rose also had extensive experience in tissue processing, embedding, sectioning, staining procedures, and immunohistochemistry. Prior to this role, they served as an Associate Scientist at Tetrad Discovery Ltd. from October 2015 to January 2019.

Overall, Rose O'Reilly has gained significant expertise in various scientific roles, including drug product process development, manufacturing development, research assistance, cell culture, neural cell differentiation, and tissue processing.

Rose O'Reilly attended the University of Bedfordshire from 2012 to 2015, where they pursued a Bachelor of Sciences (BSc(Hons)) degree in Biomedical Sciences, with a focus on the general field of study.